BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Telix Doses First US Patient In Phase Three BiPASS Prostate Cancer Imaging Trial

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces that the first patient in the United States (U.S.) has been dosed in BiPASS&...

January 20, 2026 | News

Dr Chris Chen Positions WuXi Biologics As The Defining Force Shaping The Future Of Global CRDMO Innovation

Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects ...

January 19, 2026 | News

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CR...

January 19, 2026 | News

Kelun Biotech Articulates Global Innovation Vision At J P Morgan Healthcare Conference

From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and C...

January 19, 2026 | News

Antengene Showcases Next Phase Of Global Innovation At J P Morgan Healthcare Conference

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, develop...

January 19, 2026 | News

Novartis Secures Worldwide Licence To PepLib Peptide Asset To Expand Radioligand Therapy Pipeline

Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...

January 15, 2026 | News

Allele Joins Arpa H Programme To Bioprint Patient Specific Livers With Uc San Diego

Allele Biotechnology & Pharmaceuticals, Inc. (Allele), a San Diego-based technology development and cell manufacturing company, announced its par...

January 15, 2026 | News

Aptar Powers Intranasal Covid Vaccine Trial With LuerVax And Spray Divider Delivery Systems

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, announced that its inno...

January 15, 2026 | News

Suvoda Builds A Unified Clinical Trial Platform Through Greenphire Merger And AI Innovation In 2025

Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patient...

January 14, 2026 | News

Basecamp Research And NVIDIA Achieve 97 Percent Success In AI Designed Therapies With Programmable Gene Insertion

The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene therapies. ...

January 14, 2026 | News

Oricell Raises 70M$ In Series C1 To Advance First In Class CAR T Therapy For Liver Cancer

Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced the closing of a $70M Ser...

January 14, 2026 | News

TetraScience And Thermo Fisher Join Forces To Accelerate Scientific AI Across Biopharma

TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a...

January 14, 2026 | News

Kainova Therapeutics Rebrands To Power The Next Wave Of GPCR Driven Clinical Growth

Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of corporate growth Kainova champions scientific agility, bold ambition...

January 13, 2026 | News

FDA Signals A Faster Regulatory Path For Cell And Gene Therapies

The U.S. Food and Drug Administration announced it is sharing information about the agency’s flexible appro...

January 13, 2026 | News

Stay Connected